000 01240 a2200349 4500
005 20250513225131.0
264 0 _c20001222
008 200012s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(00)03239-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan den Bosch, F
245 0 0 _aCrohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.
_h[electronic resource]
260 _bLancet (London, England)
_cNov 2000
300 _a1821-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aCrohn Disease
_xcomplications
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfliximab
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSpondylitis, Ankylosing
_xcomplications
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aKruithof, E
700 1 _aDe Vos, M
700 1 _aDe Keyser, F
700 1 _aMielants, H
773 0 _tLancet (London, England)
_gvol. 356
_gno. 9244
_gp. 1821-2
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(00)03239-6
_zAvailable from publisher's website
999 _c11058627
_d11058627